MLAB News and Press, Mesa Laboratories Inc. From 02/03/21

Mesa Laboratories (MLAB): FQ3 GAAP EPS of -$0.89 misses by $1.21.Revenue of $34.17M (+7.9% Y/Y) beats by $1.34M.Press Release For further details see: Mesa Laboratories EPS misses by $1.21, beats on revenue

LAKEWOOD, Colo., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the third quarter (“3Q21”) and nine months ended December 31, 2020. Financial highlights for the quarter and nine months ended December 31, 2020 as comp...

LAKEWOOD, Colo., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa Labs” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.  Th...

Mesa Laboratories (MLAB): Q2 GAAP EPS of $0.51 beats by $0.45.Revenue of $31.86M (+24.7% Y/Y) beats by $1.58M.Press Release For further details see: Mesa Laboratories EPS beats by $0.45, beats on revenue

LAKEWOOD, Colo., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the second quarter (“2Q21”) and six months ended September 30, 2020. Financial highlights for the quarter and six months ended September 30, 2020 as com...

Mesa Laboratories (NASDAQ: MLAB ) : Q1 Non-GAAP EPS of $1.67 misses by $0.11 ; GAAP EPS of $0.22 misses by $0.17 . More news on: Mesa Laboratories, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

LAKEWOOD, Colo., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the first quarter (“1Q21”). Financial highlights for the quarter ended June 30, 2020 as compared to last year: Revenues increased 14% Operating inc...

Source:  Mesa Laboratories, Inc. – June 16, 2020 11:30 AM ET Lakewood, Colo., June 16, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa Labs”) today announced that the underwriters for its previously announced public offering of c...

Mesa Laboratories (NASDAQ: MLAB ) has priced its public offering of 600,000 common shares at $225.00/share for gross proceeds of ~$135M. More news on: Mesa Laboratories, Inc., Healthcare stocks news, , Read more ...

Source : Mesa Laboratories, Inc. - June 9, 2020 8:15 PM ET Lakewood, Colo., June 09, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa Labs”) today announced the pricing of an underwritten public offering of 600,000 shares of its common stock at a pub...